Work

Therapeutic efficacy monitoring of pyronaridine–artesunate (Pyramax®) in treating uncomplicated Plasmodium falciparum malaria in Gia Lai province, Vietnam from 2022 to 2023

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkaf234

Authors: Nguyen Van Thanh, Huynh Hong Quang, Nguyen Ngoc San, Nguyen Kien Cuong, Nguyen Thi Minh Trinh, Chau Van Khanh, Kimberly A Edgel, Huy C Nguyen, Andrew G Letizia, Geoffrey W Birrell, Nicholas J Martin, Michael D Edstein, Marina Chavchich

Institutions: Hanoi Medical University, Vietnam Military Medical University, Institute of Malariology, Parasitology, and Entomology Quy Nhon, Naval Medical Research Unit INDO PACIFIC, Australian Defence Force Malaria and Infectious Disease Institute

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Armed Forces Health Surveillance Branch

OpenAlex ID: W4413113161

FWCI:

Cites: 15

Cited by:

Related to: 10